Fundraising FoxGlobal Health Investment Fund
Impact investorNew York · 1 people tracked
Find your way into Global Health Investment Fund
Sign up to see every warm intro you have to Global Health Investment Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Global Health Investment Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
GHIC catalyzes the development of technologies to improve human health worldwide, focusing on strengthening global health security and addressing urgent global health challenges such as infectious disease and maternal and child health. Its namesake $108 million social impact fund (GHIF) backed twelve companies developing clinical diagnostics, devices, vaccines, and therapeutics targeting diseases that disproportionately affect low- and middle-income countries, including HIV/AIDS, malaria, tuberculosis, and cholera. In partnership with BARDA, GHIC uses venture capital investments to support technologies that respond to or prevent public health emergencies like pandemics, working alongside foundations, corporations, nonprofits, and governmental agencies.
Source: firm website, verified Sep 27, 2026.
Team · 1 people
from public directories
Curt LaBelle is a Venture Partner at Adjuvant Capital with over 16 years of experience investing in healthcare companies. He was previously a managing director at Tullis Health Investors and a vice president at Investor Growth Capital. He holds a BS in economics from Brigham Young University and both MD and MBA degrees from Columbia University.
Founder mafia
2 people who came through Global Health Investment Fund went on to found or lead other companies.
What they invest in
from 5 of 7 portfolio companiesHealthtech ×5Biotech ×2Medical Devices ×2Deep Tech ×1FemTech ×1
HQs:United States×5
Investments · 7 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 22022 · 12019 · 12018 · 12017 · 17 dated
Alydia Health manufactures the JADA System, an intrauterine device that uses low-level vacuum to control postpartum hemorrhage in hospital settings.
HealthtechMedical Devices
Co-investorsAstiaAvestria VenturesGlobal Health Investment Corporation
HealthtechReno, US
Tsontcho Ianchulev(Executive Officer, Director)Charles Warden(Director)Brian Walsh(Executive Officer, Director)Bruce J. Brumfield, Jr.(Director)Glenn Rockman(Director)inJim Mazzo(Director)
Co-investorsGlobal Health Investment CorporationVisionary Ventures
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)inAmelia Degenkolb(Executive Officer, Director)in
BoardLilly DeSouza Burr(Director)Curt LaBelle(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)in
Co-investorsAvestria VenturesForeground CapitalLaerdal Million Lives FundTullis Health Investors
Ophirex is a biotech company developing varespladib, an investigational oral capsule intended to treat snakebite envenomation by inactivating a key venom toxin found in most snake species.
BiotechDeep TechHealthtechCorte Madera, US
Jerry Harrison(Co-founder; Director)Matthew R. Lewin(Founder and Board Member)inJeremy Gowler(Chief Executive Officer & Board Director)inSara Carter(Executive)Timothy Platts-Mills(Executive)Dotson(Finance leader (Controller/Finance))
.jpg)
Co-investorsTullis Health Investors
Themis offers lending backed by non-fungible tokens, allowing holders to deposit an NFT as collateral and borrow against it.
Neepa Patel(Founder)in
Co-investorsGhaf Capital PartnersLD CapitalNFXAdjuvant CapitalFelicis VenturesHadean Ventures+2 more
Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)inDaniel Couto(Executive Officer)inMark Mullikin(Executive Officer)inJeffrey Silber(Executive Officer)inChristopher Viehbacher(Director)
BoardJohn LaMattina(Director)in
Co-investorsAMR Action FundColorcon VenturesK2 HealthVenturesSalica InvestmentsSeventure PartnersBNP Paribas+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Epion Therapeutics
Portfolio news
latest coverage across their companiesVedanta Biosciences · finsmes.com · Aug 6, 2026
Frequently asked questions
- How many investments has Global Health Investment Fund made?
- Global Health Investment Fund has 7 tracked investments.
- What sectors does Global Health Investment Fund focus on?
- Global Health Investment Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Global Health Investment Fund located?
- Global Health Investment Fund is headquartered in New York, US.
Media · Podcasts & interviews
featuring the teamInterview with Curt LaBelle, Global Health Investment Fund
IPEM · Curt LaBelle
Co-investors · 2
Global Health Investment Corporation (GHIC) is an independent not-for-profit that mobilizes private, public and philanthropic capital to accelerate the development, commercialization and access to global health products and technologies.
Laerdal Million Lives Fund is an investor focused on health technology companies.
Firms observed investing alongside Global Health Investment Fund, from public investor directories. Shared companies are the overlap with Global Health Investment Fund's recorded portfolio.
Similar investors
Future Positive Capital is a venture firm that backs entrepreneurs building companies aimed at solving universal challenges at planetary scale across science and technology.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Cancer Fund is an early-stage oncology venture capital and venture-giving organization that funds diagnostics, therapeutics, and other cancer-targeting innovations, offering both charitable donation and accredited-investor pathways.
Global Health Investment Corporation (GHIC) is an independent not-for-profit that mobilizes private, public and philanthropic capital to accelerate the development, commercialization and access to global health products and technologies.